Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

CGEMCGEM
7 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in CULLINAN THERAPEUTICS INC

GOLDMAN SACHS GROUP INC holds 1M shares of CGEM (CULLINAN THERAPEUTICS INC), worth $18.2M as of 2026-Q2. The position was increased (+119.9% shares). CGEM represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$18.2M

Current Shares

1M

Total Value Change

+$9.9M

Total Shares Change

+316,224

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1M
+119.9%
$18.2M0.0%$18.21
46
2026-Q1
Decreased
455,449
-36.9%
$6.5M0.0%$15.73
0
2025-Q4
Decreased
721,864
-26.6%
$7.5M0.0%$9.92
0
2025-Q3
Increased
983,960
+40.1%
$5.8M0.0%$5.97
36
2025-Q2
Increased
702,138
+8.2%
$5.3M0.0%$7.76
29
2025-Q1
Decreased
648,957
-5.3%
$4.9M0.0%$8.02
0
2024-Q4
New
685,374
-
$8.3M0.0%$12.20
38

Other major holders of CGEM: BlackRock, Inc., BAUPOST GROUP LLC/MA, STATE STREET CORP, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used